Avoidance of Severe Cutaneous Adverse Drug Events as a First Step in Precision Neurology

JAMA Neurol. 2018 Jul 1;75(7):793-795. doi: 10.1001/jamaneurol.2018.0001.

Yijing He^{1

2

3

4}, Lucia Seminario-Vidal^{4

5}, Howard L McLeod^{1

2

3

4

6}

¹ Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
² DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida.
³ Cancer Epidemiology Program, Moffitt Cancer Center, Tampa, Florida.
⁴ University of South Florida Colleges of Medicine and Pharmacy, Tampa, Florida.
⁵ Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.
⁶ Individualized Cancer Management, Moffitt Cancer Center, Tampa, Florida.

No abstract available

Publication types